J 2013

Prevalence of remission and recovery in schizophrenia in the Czech Republic

PŘIKRYL, Radovan, Miroslava KHOLOVÁ, Hana PŘIKRYLOVÁ KUČEROVÁ and Eva ČEŠKOVÁ

Basic information

Original name

Prevalence of remission and recovery in schizophrenia in the Czech Republic

Authors

PŘIKRYL, Radovan (203 Czech Republic, guarantor, belonging to the institution), Miroslava KHOLOVÁ (203 Czech Republic), Hana PŘIKRYLOVÁ KUČEROVÁ (203 Czech Republic, belonging to the institution) and Eva ČEŠKOVÁ (203 Czech Republic, belonging to the institution)

Edition

Comprehensive Psychiatry, Philadelphia, W B SAUNDERS CO-ELSEVIER INC, 2013, 0010-440X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.256

RIV identification code

RIV/00216224:14110/13:00069545

Organization unit

Faculty of Medicine

UT WoS

000325039600048

Keywords in English

1ST-EPISODE PSYCHOSIS; FOLLOW-UP; DSM-IV; SCALE; VALIDATION; CRITERIA

Tags

Tags

International impact, Reviewed
Změněno: 31/1/2014 15:04, Soňa Böhmová

Abstract

V originále

Objective The aim of the study was to map the point prevalence of remission and recovery in patients with schizophrenia in the Czech Republic. Method The point-symptomatic remission criteria were based on the definition of remission in schizophrenia according to Andreasen, without the time criterion. The definition of complete remission contained, in addition to the point-symptomatic remission criteria, a time aspect which was determined by the absence of psychiatric hospitalisation or a change in antipsychotic medications due to inefficiency in the preceding six months. Functional remission was defined by a total score on the PSP scale in the range between 71 and 100 points. Recovery was defined by the simultaneous fulfilment of the criteria for complete and functional remission. Results A total of 481 patients with schizophrenia were included in the study. The point-symptomatic remission criteria were fulfilled in a total of 258 patients (54%); complete remission occurred in a total of 214 patients (44%). Functional remission was reached by 124 patients (26%) in total. Recovery was proven in a total of 91 patients (19%). Conclusion The ascertained data are in accordance with the results of methodologically similar studies and confirm the known trajectories of the course of schizophrenia.

Links

ED1.1.00/02.0068, research and development project
Name: CEITEC - central european institute of technology